First Procedures Conducted With Transit Scientific’s XO Score Angioplasty System to Dilate Calcified and Fibrotic Vessels
November 12, 2020—Transit Scientific announced the first procedures using the company’s XO Score to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas.
Twenty-Four–Month Data Presented From AVeNEW Trial of BD’s Covera Vascular Covered Stent
September 14, 2020—BD announced that updated 24-month data from the AVeNEW trial were presented by principal investigator Bart Dolmatch, MD, at the Cardiovascular and Interventional Radiological Society of Europe’s CIRSE 2020 Summit held online September 12-15.
Study Compares Avenu Ellipsys Access System and BD WavelinQ for pAVF Creation
September 10, 2020—Avenu Medical announced the publication of a study comparing the company’s Ellipsys vascular access system and the WavelinQ 4-F system (BD Interventional) for percutaneous arteriovenous fistula (pAVF) in patients with end-stage renal disease.
Study Shows Avenu Medical’s Ellipsys endoAVF System Reduces Time to Dialysis
September 3, 2020—Richmond Vascular Center in North Chesterfield, Virginia, announced the publication of a study demonstrating that the Ellipsys vascular access system (Avenu Medical, Inc.) reduces the time before patients with kidney failure can begin dialysis treatments while requiring fewer secondary procedures.
Mermaid Medical Group’s D*Clot HD Rotational Thrombectomy System Launched in the United States
August 25, 2020—Mermaid Medical Group, a Denmark-based provider of minimally invasive medical devices, announced commercial availability of the D*Clot HD rotational thrombectomy system in the United States.
Results Published From Medtronic’s IN.PACT AV Access Trial
August 19, 2020—Medtronic announced that the primary endpoint results from the IN.PACT AV Access randomized controlled trial of the company's In.Pact AV drug-coated balloon (DCB) were published by Robert A. Lookstein, MD, et al in The New England Journal of Medicine (2020;383:733-742). The company noted that the In.Pact AV DCB, which is approved for the treatment of failing arteriovenous (AV) access, met both its primary safety and effectiveness endpoints.
Results Published From SAVE-US IDE Study of Bluegrass Vascular’s Surfacer System
July 16, 2020—Bluegrass Vascular Technologies announced that the results of its prospective, multicenter SAVE-US study were published online by Principal Investigator Mahmood Razavi, MD, et al in The Journal of Vascular Access.
LeMaitre Vascular Acquires Artegraft
June 22, 2020—LeMaitre Vascular, Inc. announced that it has acquired the business and assets of Artegraft, Inc. Artegraft processes and sells biologic vascular grafts derived from bovine carotid arteries that are implanted primarily in hemodialysis access patients.
Infinity Angioplasty Balloon Catheter Receives 510(k) Clearance
June 16, 2020—Infinity Angioplasty Balloon Co., LLC announced that the FDA has cleared the Infinity angioplasty balloon catheter for percutaneous transluminal angioplasty treatment of peripheral arterial disease in the peripheral vasculature, including iliac, femoral, popliteal, and infrapopliteal arteries, and for the treatment of arteriovenous dialysis fistulas.
Economic Analyses Assess Medtronic's In.Pact AV DCB Versus PTA
June 13, 2020—An analysis assessing the economic impact of using the company's In.Pact AV drug-coated balloon (DCB) versus percutaneous transluminal angioplasty (PTA) in the United States healthcare system was presented by Robert Lookstein, MD, at SIR 2020 Virtual, the Society of Interventional Radiology’s 2020 annual scientific meeting held online June 13–14.
Laminate Medical’s VasQ External Support Granted FDA Breakthrough Device Designation
June 7, 2020—Laminate Medical announced that the company’s VasQ external support for the creation of arteriovenous fistulas (AVFs) in hemodialysis patients has been granted Breakthrough Device designation from the FDA.
FDA Clears Transit Scientific’s XO Score Angioplasty Scoring and Cutting Platform
June 4, 2020—Transit Scientific announced FDA clearance for the XO Score percutaneous transluminal angioplasty (PTA) scoring sheath platform for use in iliac, iliofemoral, popliteal, infrapopliteal, and renal artery disease plus synthetic and/or native arteriovenous hemodialysis fistula.
Roundtable Discussion: Percutaneous AV Fistulae: What to Expect in the Learning Curve
Perspectives on patient candidacy, technical challenges and follow-up protocols, considerations for cannulation, and steps for handling inadequate flow.
With Bart Dolmatch, MD; Alexandros Mallios, MD; Neghae Mawla, MD; Tobias Steinke, MD; and Allison Tan, MD
Roundtable Discussion: AV Use of Covered Stents: Dos and Don’ts
Experts share their tips on when, how, or if to deploy covered stents in the setting of arteriovenous grafts and/or fistulas.
With Ziv Haskal, MD, FSIR, FAHA, FACR, FCIRSE; Theodore F. Saad, MD; Haimanot (Monnie) Wasse, MD, MPH, FASN, FASDIN
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.